{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:27:19Z","timestamp":1790476039657,"version":"4.1.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:p>To date, the Endophthalmitis Vitrectomy Study (EVS) has remained the hallmark of evidence-based management of acute bacterial endophthalmitis after cataract surgery with an intraocular lens. In the last quarter-century since its publication, several studies have reported that the microbiological spectrum of endophthalmitis is not the same across the world; there is emerging antibiotic resistance of gram-negative microorganisms to the EVS recommended antibiotics; there are newer molecules that could cross the blood-retinal barrier; the advances in vitreous surgery have become safer than before, and there are newer methods of microbiological evaluation. One of the often-mentioned drawbacks of the EVS was not recruiting grossly infected eyes with poor visibility of the iris and vitreous. Keeping these factors in mind, a new prospective multi-centered randomized study, the Endophthalmitis Management Study (EMS), is designed. The EMS will recruit all post-cataract surgery endophthalmitis patients irrespective of severity (including suspected fungal infection); the EMS will use quantifiable inflammatory score instead of the presenting vision to allocate for surgery, randomize the eyes to two different combinations of intravitreal antibiotics and use the newer microbiological diagnostic techniques. We believe the EMS findings will complement the EVS recommendations.<\/jats:p>","DOI":"10.4103\/ijo.ijo_199_21","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T14:43:02Z","timestamp":1624632182000},"page":"1936-1941","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":21,"title":["Endophthalmitis management study. Report #1. Protocol"],"prefix":"10.4103","volume":"69","author":[{"given":"Taraprasad","family":"Das","sequence":"first","affiliation":[{"name":"Srimati Kanuri Santhamma Centre for Vitreoretinal Diseases, Kallam Anji Reddy Campus, L. V. Prasad Eye Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek P","family":"Dave","sequence":"additional","affiliation":[{"name":"Srimati Kanuri Santhamma Centre for Vitreoretinal Diseases, Kallam Anji Reddy Campus, L. V. Prasad Eye Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avantika","family":"Dogra","sequence":"additional","affiliation":[{"name":"Srimati Kanuri Santhamma Centre for Vitreoretinal Diseases, Kallam Anji Reddy Campus, L. V. Prasad Eye Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joveeta","family":"Joseph","sequence":"additional","affiliation":[{"name":"Jhaveri Microbiology Center, Kallam Anji Reddy Campus, L. V. Prasad Eye Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savitri","family":"Sharma","sequence":"additional","affiliation":[{"name":"Jhaveri Microbiology Center, Kallam Anji Reddy Campus, L. V. Prasad Eye Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the EMS working group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,6,18]]},"reference":[{"key":"R1-20260523","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1001\/archopht.1995.01100120009001","article-title":"Results of the endophthalmitis vitrectomy study:A randomized trial of immediate vitrectomy and intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis","volume":"113","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"R2-20260523","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.4103\/ijo.IJO_755_17","article-title":"Redefining evidence in the management of acute post-cataract surgery endophthalmitis in India-The 2014 Adenwalla Oration, All India Ophthalmological Society","volume":"65","author":"Das","year":"2017","journal-title":"Indian J Ophthalmol"},{"key":"R3-20260523","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1136\/bjo.83.9.1050","article-title":"Intravitreal dexamethasone in exogenous bacterial endophthalmitis:Results of a prospective randomized study","volume":"83","author":"Das","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"R4-20260523","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1099\/00207713-50-4-1553","article-title":"Arthrobacter flavus sp. nov., a psychrotropic bacterium isolated from a pond in Mc Murdo Dry Valley, Antarctica","volume":"50","author":"Reddy","year":"2000","journal-title":"Int J Syst Evol Microbiol"},{"key":"R5-20260523","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41598-018-37502-w","article-title":"New insights into culture negative endophthalmitis by unbiased next generation sequencing","volume":"9","author":"Deshmukh","year":"2019","journal-title":"Sci Rep"},{"key":"R6-20260523","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2147\/OPTH.S185716","article-title":"Endoscopic vitrectomy in endophthalmitis:Initial experience of 33 cases at a tertiary eye care center","volume":"13","author":"Dave","year":"2019","journal-title":"Clin Ophthalmol"},{"key":"R7-20260523","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/bjo.2007.121715","article-title":"Validation of a computerized logMAR visual acuity measurement system (COMPlog):Comparison with ETDRS and electronic ETDRS testing algorithm in adults and amblyopic children","volume":"92","author":"Laidlaw","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R8-20260523","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archopht.126.4.559","article-title":"Legacy of the endophthalmitis vitrectomy study","volume":"126","author":"Flynn","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"R9-20260523","doi-asserted-by":"crossref","first-page":"196094","DOI":"10.1155\/2012\/196094","article-title":"Role of inflammation in endophthalmitis","volume":"2012","author":"Vallejo- Garcia","year":"2012","journal-title":"Mediators Inflamm"},{"key":"R11-20260523","doi-asserted-by":"crossref","first-page":"6285869","DOI":"10.1155\/2017\/6285869","article-title":"Review of small gauge vitrectomy:Progress and innovations","volume":"2017","author":"Mohamed","year":"2017","journal-title":"J Ophthalmol"},{"key":"R12-20260523","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1001\/archopht.124.2.178","article-title":"Vitreous and aqueous penetration of orally administered moxiflooxacin in humans","volume":"124","author":"Hariprasad","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"R13-20260523","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1755-3768.2008.01323.x","article-title":"Evaluation of vitreous levels of gatifloxacin after systemic administration in inflamed and non-inflamed eyes","volume":"87","author":"Rajpal","year":"2009","journal-title":"Acta Ophthalmol"},{"key":"R14-20260523","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0161-6420(92)31943-8","article-title":"Intravitreal penetration of oral ciprofloxacin in humans","volume":"99","author":"El Baba","year":"1992","journal-title":"Ophthalmology"},{"key":"R15-20260523","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1007\/s00417-005-0133-1","article-title":"Intravitreal dexamethasone as adjuvant in the treatment of postoperative endophthalmitis:A prospective randomized trial","volume":"243","author":"Gan","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R16-20260523","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1136\/bjo.2010.187963","article-title":"Adjunctive use of intravitreal dexamethasone in presumed bacterial endophthalmitis:A randomised trial","volume":"95","author":"Albrecht","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"R17-20260523","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/00006982-200605000-00008","article-title":"Role of intravitreal triamcinolone acetonide in the treatment of postoperative endophthalmitis","volume":"26","author":"Falk","year":"2006","journal-title":"Retina"},{"key":"R18-20260523","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.ajo.2005.11.043","article-title":"Intravitreal triamcinolone acetonide in the management of exogenous bacterial endophthalmitis","volume":"141","author":"Pathengay","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R19-20260523","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0161-6420(99)00139-6","article-title":"Visual outcomes following the use of intravitreal steroids in the treatment of postoperative endophthalmitis","volume":"107","author":"Shah","year":"2000","journal-title":"Ophthalmology"},{"key":"R20-20260523","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12348-016-0113-0","article-title":"Comparison of clinico-microbiological profile and treatment outcome of in-house and referred post cataract surgery endophthalmitis in a teaching tertiary care center in south India","volume":"6","author":"Ambiya","year":"2016","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"R21-20260523","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/ceo.12833","article-title":"Clinical presentations, risk factors, and outcome of ceftazidime- resistant gram-negative endophthalmitis","volume":"45","author":"Dave","year":"2017","journal-title":"Clin Exp Ophthalmol"},{"key":"R22-20260523","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1038\/s41433-019-0380-8","article-title":"Trends in microbiological spectrum of endophthalmitis in India:A review of 25 years","volume":"33","author":"Joseph","year":"2019","journal-title":"Eye"},{"key":"R23-20260523","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12348-014-0022-z","article-title":"Pharmacokinetics of intravitreal antibiotics in endophthalmitis","volume":"4","author":"Radhika","year":"2014","journal-title":"J Ophthalmic Inflamm Infect"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_199_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:26:50Z","timestamp":1786735610000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_199_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,18]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_199_21","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,18]]},"assertion":[{"value":"2021-01-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}